For now, Indian patients will be able to see the data from the reader on the device only. Abbott is expected to launch its software to collate this data on smart devices in 2021.
An analysis by the Indian Pharmacopoeia Commission shows they have received 290 adverse reports — of 556 reports logged so far this year — for devices manufactured by Abbott.
On September 8, 2017, Abbott Healthcare requested the NPPA to let it withdraw Absorb and Absorb GT1 brands of Bioresorbable Vascular Scaffold from the Indian market as “it is stopping the manufacturing” of these two brands globally because of “low commercial uptake”.
Assam orchids to Navi Mumbai’s lotus design: India on most beautiful airports list
Lifestyle55 min ago
Guwahati and Navi Mumbai airports have been recognized as two of the world's most beautiful airports in 2026 by Prix Versailles. These airports showcase the region's culture and natural beauty, incorporating elements like bamboo and lotus-inspired designs. This prestigious award not only recognizes the airports' unique architecture but also brings attention to Northeast's rich cultural heritage.
